Pacer Advisors Inc. Increases Position in Dolby Laboratories $DLB

Pacer Advisors Inc. raised its position in shares of Dolby Laboratories (NYSE:DLBFree Report) by 98.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 443,897 shares of the electronics maker’s stock after buying an additional 219,901 shares during the period. Pacer Advisors Inc.’s holdings in Dolby Laboratories were worth $32,125,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Dolby Laboratories by 7.8% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock worth $1,172,000 after acquiring an additional 1,146 shares in the last quarter. Campbell & CO Investment Adviser LLC grew its position in Dolby Laboratories by 193.2% in the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 17,275 shares of the electronics maker’s stock valued at $1,283,000 after acquiring an additional 11,384 shares in the last quarter. Boston Trust Walden Corp increased its stake in Dolby Laboratories by 2.1% during the second quarter. Boston Trust Walden Corp now owns 1,098,218 shares of the electronics maker’s stock worth $81,554,000 after purchasing an additional 22,404 shares during the period. Sequoia Financial Advisors LLC acquired a new stake in shares of Dolby Laboratories during the second quarter worth about $550,000. Finally, Clifford Capital Partners LLC lifted its position in shares of Dolby Laboratories by 3.1% during the second quarter. Clifford Capital Partners LLC now owns 264,059 shares of the electronics maker’s stock worth $19,609,000 after purchasing an additional 7,871 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Trading Down 0.7%

Shares of DLB opened at $65.69 on Friday. The firm has a market capitalization of $6.27 billion, a price-to-earnings ratio of 24.98 and a beta of 0.89. The firm’s fifty day simple moving average is $66.51 and its 200-day simple moving average is $70.85. Dolby Laboratories has a twelve month low of $64.02 and a twelve month high of $89.66.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The firm had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same quarter in the prior year, the company posted $0.61 earnings per share. Dolby Laboratories’s revenue for the quarter was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 2.2%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 54.75%.

Insiders Place Their Bets

In other news, EVP Mark Andrew Sherman sold 9,109 shares of the business’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $66.73, for a total transaction of $607,843.57. Following the completion of the sale, the executive vice president owned 73,054 shares in the company, valued at approximately $4,874,893.42. The trade was a 11.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP John D. Couling sold 7,273 shares of the stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $68.75, for a total transaction of $500,018.75. Following the completion of the transaction, the senior vice president directly owned 108,065 shares in the company, valued at $7,429,468.75. This trade represents a 6.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 162,120 shares of company stock valued at $10,906,559. 37.93% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

DLB has been the subject of a number of research reports. Barrington Research dropped their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. Rosenblatt Securities dropped their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Baird R W upgraded Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, December 20th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $92.00.

View Our Latest Research Report on DLB

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Read More

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.